Chemours Q4 2021 Earnings Report
Key Takeaways
Chemours reported a strong fourth quarter with net sales of $1.6 billion, up 18% year-over-year, and adjusted EBITDA of $307 million, up 25% year-over-year. The company's performance was driven by higher pricing and strong demand across its segments, particularly in Titanium Technologies and Advanced Performance Materials.
Net sales increased by 18% year-over-year to $1.6 billion.
Net income was $233 million, with EPS of $1.40, up $1.29 year-over-year.
Adjusted EBITDA increased by 25% year-over-year to $307 million.
The company completed the sale of Mining Solutions for $521 million.
Chemours
Chemours
Chemours Revenue by Segment
Forward Guidance
The company expects to deliver 2022 Adjusted EBITDA within a range of $1.3 billion to $1.425 billion. Adjusted EPS is projected to be between $4.07 and $4.70. The company expects Free Cash Flow of greater than $500 million, inclusive of approximately $400 million of capital expenditures.
Positive Outlook
- Continued economic recovery from the challenges caused by the global pandemic
- Normalization of supply chains early in 2022
- Driving top-line growth
- Improving the underlying earnings quality of the business
- Capturing the significant secular growth potential of our core businesses